Cite
Safety and risk of febrile recurrence after early antibiotic discontinuation in high-risk neutropenic patients with haematological malignancies: a multicentre observational study.
MLA
Paret, Raphael, et al. “Safety and Risk of Febrile Recurrence after Early Antibiotic Discontinuation in High-Risk Neutropenic Patients with Haematological Malignancies: A Multicentre Observational Study.” Journal of Antimicrobial Chemotherapy (JAC), vol. 77, no. 9, Sept. 2022, pp. 2546–56. EBSCOhost, https://doi.org/10.1093/jac/dkac190.
APA
Paret, R., Bourgeois, A. L., Guillerm, G., Tessoulin, B., Rezig, S., Gastinne, T., Couturier, M. A., Boutoille, D., Lecomte, R., Ader, F., Gouill, S. L., Ansart, S., Talarmin, J. P., Gaborit, B., Le Bourgeois, A., & Le Gouill, S. (2022). Safety and risk of febrile recurrence after early antibiotic discontinuation in high-risk neutropenic patients with haematological malignancies: a multicentre observational study. Journal of Antimicrobial Chemotherapy (JAC), 77(9), 2546–2556. https://doi.org/10.1093/jac/dkac190
Chicago
Paret, Raphael, Amandine Le Bourgeois, Gaëlle Guillerm, Benoit Tessoulin, Schéhérazade Rezig, Thomas Gastinne, Marie Anne Couturier, et al. 2022. “Safety and Risk of Febrile Recurrence after Early Antibiotic Discontinuation in High-Risk Neutropenic Patients with Haematological Malignancies: A Multicentre Observational Study.” Journal of Antimicrobial Chemotherapy (JAC) 77 (9): 2546–56. doi:10.1093/jac/dkac190.